CJC-1295 without DAC 5mg +IPA 5mg)

Sold by case = 10 vials

CJC-1295 (without DAC) + Ipamorelin Combination

For Research Use Only. Not for Human or Veterinary Consumption.

This combination pairs CJC-1295 (without DAC), a growth hormone-releasing hormone (GHRH) analog, with Ipamorelin, a selective growth hormone secretagogue. Together, they are used in laboratory research to study synergistic stimulation of endogenous growth hormone release via complementary mechanisms involving pituitary receptor activation. Researchers investigate this dual approach to better understand growth hormone axis modulation, endocrine signaling, and anabolic processes in experimental models.

This product is intended strictly for qualified laboratory research and is not approved for therapeutic, diagnostic, or human use.

Mechanism of Action

• CJC-1295 binds to GHRH receptors on pituitary somatotrophs, stimulating growth hormone release via endogenous pathways in experimental models.

• Ipamorelin acts as a selective ghrelin receptor agonist, promoting growth hormone secretion through a complementary mechanism.

• The combination allows investigation of synergistic effects on growth hormone axis regulation and anabolic signaling in laboratory settings.

• Supports research into endocrine feedback loops, tissue growth, and metabolic regulation under controlled conditions.